FDA — authorised 22 August 2002
- Application: NDA021241
- Marketing authorisation holder: JANSSEN PHARMS
- Local brand name: ORTHO TRI-CYCLEN LO
- Indication: TABLET — ORAL-28
- Status: approved
🇺🇸 Ortho Tri-Cyclen LO in United States
FDA authorised Ortho Tri-Cyclen LO on 22 August 2002
Marketing authorisation
Other Contraception / Gynecology approved in United States
Frequently asked questions
Is Ortho Tri-Cyclen LO approved in United States?
Yes. FDA authorised it on 22 August 2002.
Who is the marketing authorisation holder for Ortho Tri-Cyclen LO in United States?
JANSSEN PHARMS holds the US marketing authorisation.